Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy

计划入组 166 人 · 首次发布于 2014 年 9 月 15 日

Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)

计划入组 14 人 · 首次发布于 2015 年 12 月 11 日

Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick

计划入组 29 人 · 首次发布于 2014 年 11 月 2 日

Aminolevulinic Acid(Ameluz, Gliolan, Levulan)

C₅H₉NO₃ · Rx

BLU-451

UNIVERZITET U BEOGRADU

Serbia

SVEUCILISTE U MOSTARU

Bosnia and Herzegovina

UNIVERZITET U NOVOM SADU

Serbia

FDA Approves Sun Pharma's Next-Generation LED BLU-U Device for Actinic Keratosis Treatment

Photodynamic Therapy Shows Promise in Cancer Treatment with Global Market Expected to Reach $6 Billion by 2030

FDA Rejects Blu Disposable E-Cigarette Marketing Application Over Dual-Use Concerns